Later studies have shown that MOZ-TIF2 can promote self-renewal of the committed progenitor cells, which allows preleukemic expansion of cells in the bone marrow facilitating the development of AML (Huntly et al., 2004). This evidence concerns the gene NCOA2 and acute myeloid leukemia.